Development and external validation of a prediction model for the risk of relapse in psoriasis after discontinuation of biologics
BackgroundSome patients with psoriasis experience relapses shortly after discontinuation of biologics. However, there is a lack of risk prediction tools to identify those at high risk of relapse.ObjectiveTo develop and validate a risk prediction model for psoriasis relapse after biologics discontinu...
Saved in:
| Main Authors: | Shan Huang, Bailin Chen, Yiming Qi, Xingwu Duan, Yanping Bai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1488096/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalized prediction of psoriasis relapse post-biologic discontinuation: a machine learning-driven population cohort study
by: Shan Huang, et al.
Published: (2025-12-01) -
Tobacco Smoking Was Positively Associated with Disease Relapse at week 24 and 48 Among Patients with Psoriasis Vulgaris in Shanghai: A Prospective Study
by: Shen F, et al.
Published: (2025-07-01) -
Role of methotrexate in biologics use with psoriasis and psoriatic arthritis
by: Ting-Ting Cheng, et al.
Published: (2025-04-01) -
Pathogenetic mechanisms of biological agents in managing of relapsing polychondritis
by: E. G. Khaleva, et al.
Published: (2018-07-01) -
Factors Influencing Relapse After Omalizumab in Chronic Urticaria. Does the Method of Discontinuation Influence Relapse?
by: Petek Üstün, et al.
Published: (2025-07-01)